Showing 21 - 30 of 41 posts
https://www.coltonconsortium.org/publications/the-2024-vasculitis-foundation-quality-care-summit-seeking-strategies-to-improve-care-for-all-patients/
https://www.coltonconsortium.org/publications/microbiome-research-in-autoimmune-and-immune-mediated-inflammatory-diseases-lessons-advances-and-unmet-needs/
https://www.coltonconsortium.org/publications/multimorbidity-in-psoriasis-as-a-risk-factor-for-psoriatic-arthritis-a-population-based-study/
https://www.coltonconsortium.org/publications/multiple-sclerosis-and-covid-19-interactions-and-unresolved-issues/
https://www.coltonconsortium.org/publications/personalized-treatment-decision-algorithms-for-the-clinical-application-of-serum-neurofilament-light-chain-in-multiple-sclerosis-a-modified-delphi-study/
https://www.coltonconsortium.org/publications/psoriatic-arthritis-phenotype-clusters-and-their-association-with-treatment-response-a-real-world-longitudinal-cohort-study-from-the-psoriatic-arthritis-research-consortium/
https://www.coltonconsortium.org/publications/quadriparesis-and-paraparesis-following-chimeric-antigen-receptor-t-cell-therapy-in-children-and-adolescents/
https://www.coltonconsortium.org/publications/racial-and-ethnic-determinants-of-psoriatic-arthritis-phenotypes-and-disease-activity/
https://www.coltonconsortium.org/publications/differences-in-disease-characteristics-and-treatment-exposures-between-paediatric-and-adult-onset-inflammatory-bowel-disease-using-a-registry-based-cohort/
https://www.coltonconsortium.org/publications/effect-of-bimekizumab-on-patient-reported-disease-impact-in-patients-with-psoriatic-arthritis-1-year-results-from-two-phase-3-studies/
